formic acid has been researched along with vx-770 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acosta, EP; Anderson, JD; Dowell, AE; Guimbellot, JS; Kerstner-Wood, CD; Liu, Z; Reed-Walker, KD; Ryan, KJ | 1 |
| Can, NÖ; Erdoğan Uzunoğlu, Ü; Levent, S; Özcan, S | 1 |
2 other study(ies) available for formic acid and vx-770
| Article | Year |
|---|---|
Quantitation of cystic fibrosis triple combination therapy, elexacaftor/tezacaftor/ivacaftor, in human plasma and cellular lysate.
Topics: Aminophenols; Benzodioxoles; Chromatography, Liquid; Cystic Fibrosis; Humans; Tandem Mass Spectrometry | 2022 |
Liquid chromatographic determination of lumacaftor in the presence of ivacaftor and identification of five novel degradation products using high-performance liquid chromatography ion trap time-of-flight mass spectrometry.
Topics: Aminophenols; Benzodioxoles; Chromatography, High Pressure Liquid; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Humans; Mass Spectrometry; Mutation | 2023 |